Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines

Journal of Immunology

Volumn 164, Issue 7, 2000, Pages 3698-3704

  Arulanandam, Bernard P ^a   Mittler, James N ^b,c   Lee, William T ^b,c   O'Toole, Margot ^d   Metzger, Dennis W ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b WADSWORTH CENTER   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOLOGICAL MEMORY; INFLUENZA VACCINATION; INFLUENZA VIRUS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SURVIVAL; VACCINATION; VIRUS INFECTION;

EID: 0034177875     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.7.3698     Document Type: Article

References (51)

1. Billingham, R. E., L. Brent, and P. B. Medawar. 1953. Actively acquired tolerance of foreign cells. Nature 172:603.
2. Spear, P. G., and G. M. Edelman. 1974. Maturation of the humoral immune response in mice. J. Exp. Med. 139:249.
3. Mosier, D. E., and B. M. Johnson. 1975. Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes. J. Exp. Med. 141:216.
4. Burnet, F. M., and F. Fenner. 1949. The Production of Antibodies. Macmillan, Melbourne.
5. Kovarik, J., and C. A. Siegrist. 1998. Immunity in early life. Immunol. Today 19:150.
6. Ridge, J. P., E. J. Fuchs, and P. Matzinger. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723.
7. Chelvarajan, R. L., N. L. Gilbert, and S. Bondada. 1998. Neonatal murine B lymphocytes respond to polysaccharide antigens in the presence of IL-1 and IL-6. J. Immunol. 161:3315.
8. Forsthuber, T., H. C. Yip, and P. V. Lehmann. 1996. Induction of TH1 and TH2 immunity in neonatal mice. Science 271:1728.
9. Barrios, C., P. Brawand, M. Berney, C. Brandt, P. H. Lambert, and C. A. Siegrist. 1996. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur. J. Immunol. 26:1489.
10. Barrios, C., C. Brandt, M. Berney, P. H. Lambert, and C. A. Siegrist. 1996. Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects. Eur. J. Immunol. 26:2666.
11. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
12. + T cells. J. Immunol. 154:5071.
13. Trinchieri, G., and P. Scott. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res. Immunol. 146:423.
14. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D. H. Presky. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495.
15. Buchanan, J. M., L. A. Vogel, V. H. Van Cleave, and D. W. Metzger. 1995. Interleukin 12 alters the isotype-restricted antibody response of mice to hen egg-white lysozyme. Int. Immunol. 7:1519.
16. Metzger, D. W., J. M. Buchanan, J. T. Collins, T. L. Lester, K. S. Murray, V. H. Van Cleave, L. A. Vogel, and W. A. Dunnick. 1996. Enhancement of humoral immunity by interleukin-12. Ann. NY Acad. Sci. 795:100.
17. Metzger, D. W., R. M. McNutt, J. T. Collins, J. M. Buchanan, V. H. Van Cleave, and W. A. Dunnick. 1997. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-γ-dependent and -independent mechanisms. Eur. J. Immunol. 27:1958.
18. McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wolf, and A. K. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172.
19. Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately, and F. D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047.
20. Germann, T., M. Bongartz, H. Dlugonska, H. Hess, E. Schmitt, L. Kolbe, E. Kolsch, F. J. Podlaski, M. K. Gately, and E. Rude. 1995. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25:823.
21. Wynn, T. A., A. Reynolds, S. James, A. W. Cheever, P. Caspar, S. Hieny, D. Jankovic, M. Strand, and A. Sher. 1996. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J. Immunol. 157:4068.
22. Bliss, J., V. Van Cleave, K. Murray, A. Wiencis, M. Ketchum, R. Maylor, T. Haire, C. Resmini, A. K. Abbas, and S. F. Wolf. 1996. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J. Immunol. 156:887.
23. Arulanandam, B. P., V. H. Van Cleave, and D. W. Metzger. 1999. Interleukin-12 is a potent neonatal vaccine adjuvant. Eur. J. Immunol. 29:256.
24. Suen, Y., S. M. Lee, J. Qian, C. van de Ven, and M. S. Cairo. 1998. Dysregulation of lymphokine production in the neonate and its impact on neonatal cell mediated immunity. Vaccine 16:1369.
25. Urban, J. F. Jr., R. Fayer, S. J. Chen, W. C. Gause, M. K. Gately, and F. D. Finkelman. 1996. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J. Immunol. 156: 263.
26. Mancuso, G., V. Cusumano, F. Genovese, M. Gambuzza, C. Beninati, and G. Teti. 1997. Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci. Infect. Immun. 65:3731.
27. Buchanan, R. M., B. P. Arulanandam, and D. W. Metzger. 1998. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells. J. Immunol. 161:5525.
28. Gerosa, F., C. Paganin, D. Peritt, F. Paiola, M. T. Scupoli, M. Aste-Amezaga, I. Frank, and G. Trinchieri. 1996. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J. Exp. Med. 183:2559.
29. Sher, A., D. Jankovic, A. Cheever, and T. Wynn. 1996. An IL-12-based vaccine approach for preventing immunopathology in schistosomiasis. Ann. NY Acad. Sci. 795:202.
30. Kitamura, D., J. Roes, R. Kuhn, and K. A. Rajewsky. 1991. B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350:423.
31. Snapper, C. M., C. Peschel, and W. E. Paul. 1988. IFN-γ stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140:2121.
32. Burton, J. D., R. N. Bamford, C. Peters, A. J. Grant, G. Kurys, C. K. Goldman, J. Brennan, E. Roessler, and T. A. Waldmann. 1994. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4935.
33. Armitage, R. J., B. M. Macduff, J. Eisenman, R. Paxton, and K. H. Grabstein. 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:483.
34. + hematopoietic progenitor cells. Blood 87:2632.
35. - CD4 T cells. J. Clin. Invest. 94:1352.
36. Coutelier, J. P., J. T. van der Logt, F. W. Heessen, G. Warnier, and J. van Snick. 1987. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 165:64.
37. Tang, Y. W., and B. S. Graham. 1995. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J. Infect. Dis. 172:734.
38. Arulanandam, B. P., M. O'Toole, and D. W. Metzger. 1999. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. J. Infect. Dis. 180:940.
39. Monteiro, J. M., C. Harvey, and G. Trinchieri. 1998. Role of interleukin-12 in primary influenza virus infection. J. Virol. 72:4825.
40. Epstein, S. L., C. Y. Lo, J. A. Misplon, and J. R. Bennink. 1998. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160:322.
41. Gerhard, W., K. Mozdzanowska, M. Furchner, G. Washko, and K. Maiese. 1997. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 159:95.
42. Graham, M. B., and T. J. Braciale. 1997. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 186:2063.
43. + T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Virology 239:217.
44. + T cells is inefficient in the absence of B cells. J. Virol. 72:882.
45. Wright, P. F. 1998. Infectious diseases in early life in industrialized countries. Vaccine 16:1355.
46. Mulholland, K. 1998. Serious infections in young infants in developing countries. Vaccine 16:1360.
47. Gupta, R. K., P. Griffin, Jr., A. C. Chang, R. Rivera, R. Anderson, B. Rost, D. Cecchini, M. Nicholson, and G. R. Siber. 1996. The role of adjuvants and delivery systems in modulation of immune response to vaccines. In Novel Strategies in Design and Production of Vaccines. S. Cohen and A. Shafferman, eds. Plenum Press, NY, p. 105.
48. Martinez, X., C. Brandt, F. Saddallah, C. Tougne, C. Barrios, F. Wild, G. Dougan, P.-H. Lambert, and C. A. Siegrist. 1998. DNA immunization circumvents deficient induction of T helper type I and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl. Acad. Sci. USA 94:8726.
49. Bot, A., S. Antohi, S. Bot, A. G. Sastre, and C. Bona. 1998. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene. Int. Immunol. 9:1641.
50. Chu, R. S., O. S. Targoni, A. M. Krieg, P. V. Lehmann, and C. V. Harding. 1997. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:1623.
51. Brazolot Millan, C. L., R. Weeratna, A. M. Krieg, C. A. Siegrist, and H. L. Davis. 1998. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. USA 95:15553.